NCT07130318 Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
| NCT ID | NCT07130318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Familial Mediterranean Fever |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-08 |
| Primary Completion | 2026-01-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-08 with a primary completion date of 2026-01-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Familial Mediterranean fever (FMF) affect liver and causes some dysfunctions including non-alcoholic fatty liver.. still exercise and diet limitation is the treatment for this case
Eligibility Criteria
Inclusion Criteria: * familial Mediterrean fever women * obese women * women who have fatty live (non alcoholic type) Exclusion Criteria: * cardiac patients * respiratory disease * renal disease * cancer
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07130318 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 55 Years, studying Familial Mediterranean Fever. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07130318 currently recruiting?
Yes, NCT07130318 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07130318 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07130318 clinical trial?
NCT07130318 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.